• 

  Fact Check: Bharat Biotech's Covaxin approved for children above 12 years?

  India | May 10, 2021 12:37 IST

  Government has said that a tweet claiming that Covaxin has been approved for children above 12 years of age is fake.

• 

  Lakshadweep, Haryana, Assam top in COVID vaccine wastage

  India | May 09, 2021 16:55 IST

  Amidst increasing Covid-19 vaccine demands in the country, wastage of the key injection has been a matter of concern for the government with reports of highest 22.74 per cent wastage reported in Lakshadweep till 8 a.m. on Sunday. 

• 

  DRDO scientist Anant Narayan Bhatt explains how 2DG drug helps body to fight with covid 19

  News | May 09, 2021 15:20 IST

  The drug has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's Laboratories in Hyderabad. The 2-DG comes in powder form in sachet and is taken orally by dissolving it in water.

• 

  WHO panel OKs emergency use of China’s Sinopharm vaccine

  World | May 07, 2021 22:32 IST

  Aside from efficacy numbers, the Chinese manufacturer has released very little public data about its two vaccines – one developed by its Beijing Institute of Biological Products and the other by the Wuhan Institute of Biological Products.

• 

  COVID 19 Vaccination: Huge crowd cause chaos at Rajawadi hospital in Mumbai

  News | May 07, 2021 14:29 IST

  As the country fights against the second wave of COVID pandemic, the state of Maharashtra sees vaccine drives facing a different challenge with limited doses and crowding the public. Vaccination centres in the city of Mumbai are facing massive crowding. Watch to know more.

• 

  Over 16.48 Crore COVID vaccine doses administered so far: Health Ministry

  India | May 06, 2021 23:40 IST

  It said 2,62,932 beneficiaries in the 18-44 age group received the first dose of the vaccine across 12 states and Union territories on Thursday. 

• 

  Germany makes AstraZeneca jabs available immediately to all adults

  World | May 06, 2021 23:30 IST

  Health authorities have said that benefits of getting inoculated against COVID-19 far outweigh any risks, and Spahn said many people still waiting for an appointment for their first shot would be happy to receive the AstraZeneca vaccine.

• 

  95 million COVID vaccines doses handled by AAI-managed airports

  India | May 06, 2021 21:53 IST

  The AAI, which works under the Civil Aviation Ministry, owns and manages over 100 airports across India.

• 

  Over 16 crore COVID-19 vaccine doses administered in country

  India | May 05, 2021 15:29 IST

  The ministry said 6,71,285 beneficiaries in the age group of 18-44 years have received their first dose of COVID vaccine across 12 states and UTs.

• 

  Watch All India report of COVID vaccination drive

  News | May 05, 2021 13:46 IST

  Watch All India report of COVID vaccination drive

• 

  Working closely with govt, got all kinds of support: Adar Poonawalla on vaccine production

  India | May 03, 2021 17:02 IST

  Serum Institute of India (SII) CEO Adar Poonawalla has issued a statement regarding vaccine availability in the country and ramping up its production. SII issued Poonawalla's statement after some of his comments on vaccine production were misinterpreted.

Advertisement
• 

  'Corona is a scam' approach misplaced, we may be tired but the virus isn't: Govt

  India | April 30, 2021 19:56 IST

  Seeking everyone's support to manage the situation, Joint Secretary in the Union Health Ministry Lav Agarwal said that "misplaced fear" was also being observed among people and urged them not to stock oxygen cylinders at home.  

• 

  Supreme Court asks Centre to explain the logic behind Covid-19 vaccine pricing

  News | April 30, 2021 14:00 IST

  The Supreme Court on Tuesday asked the Union of India (UOI) to explain the basis and rationale adopted with respect to the pricing of Covid-19 vaccines and other necessary items.

• 

  Covaxin price reduced from Rs 600 to Rs 400 per dose for states, says Bharat Biotech

  India | April 29, 2021 18:15 IST

  Covaxin vaccine maker Bharat Biotech on Thursday announced a drop in the price of its vaccine that will be made available to the state governments.

• 

  We have given assistance, we are getting assistance: Foreign Secy Shringla on foreign help to India

  India | April 29, 2021 17:27 IST

  The coronavirus pandemic has triggered an unprecedented situation and India is not looking at medical supplies and assistance by its partners and friends in terms of any policy framework, Foreign Secretary Harsh Vardhan Shringla said on Thursday.

• 

  Vaccine for 18-plus: Madhya Pradesh prepares for ‘Herculean’ task

  News | April 29, 2021 12:20 IST

  With the vaccination process for persons aged above 18 years beginning from May 1 onwards, the government has placed an order for 45 lakh doses of Covishield for the first month.

• 

  Can't be mute spectator during national crisis, says Supreme Court; questions vaccine pricing

  India | April 27, 2021 15:06 IST

  The Supreme Court also questioned the rationale behind different pricing of Covid vaccines. The court has asked the Centre to clarify over the issue.

• 

  Long queue of people seen at BKC jumbo vaccination centre in Mumbai

  News | April 27, 2021 12:40 IST

  Amid rising rising coronavirus cases across the country, long queue of people seen at BKC jumbo vaccination centre in Mumbai. From May 1 everyone above 18-yrs will also get eligible for the vaccination.

• 

  BJP govt created barrier by hiking COVID vaccines prices: K'taka Congress

  India | April 25, 2021 18:41 IST

  The principal opposition party also questioned the Yediyurappa government for not announcing vaccines free of cost yet for all.

• 

  CoWin, Aarogya Setu: How to register for COVID-19 vaccine online

  Technology | April 26, 2021 12:14 IST

  COVID-19 vaccine registration has now been made mandatory for people of 18 years to 45 years of age. Here's how you can register for the vaccine via CoWin portal or Aarogya Setu app.